John Rogers

Last Update: 03-10-2017

Number of Stocks: 191
Number of New Stocks: 14

Total Value: $8,471 Mil
Q/Q Turnover: 5%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

John Rogers' s Profile & Performance

Profile

John Rogers is the Founder of Ariel Investment, LLC, which he started in 1983. As of 2008, the firm had over $15.5 billion in assets under management. John manages Ariel's small and mid-cap institutional portfolios as well as the Ariel Fund (ARGFX) and Ariel Appreciation Fund (CAAPX). He is also a long-term Forbes columnist writing a column called "Patient Investor."

Web Page:http://www.arielmutualfunds.com/

Investing Philosophy

Rogers has concentrated his investment selection on small and medium-sized companies whose share prices are undervalued. He believes that patience, independent thinking, and a long-term outlook are essential to achieving good returns. His fund seeks to purchase companies whose prospects include high barriers to entry, sustainable competitive advantages, and predictable fundamentals that allow for double digit cash earnings growth. Rogers purchases companies when they are trading at a low valuation relative to potential earnings (p/e less than 13x forward cash earnings) and/or a low valuation relative to intrinsic worth (40% discount to private market value - PMV).

Total Holding History

Performance of Ariel Fund

YearReturn (%)S&P500 (%)Excess Gain (%)
201615.5611.963.6
2015-4.11.38-5.5
201410.9513.69-2.7
3-Year Cumulative23 (7.1%/year)29 (8.9%/year)-6 (-1.8%/year)
201344.6832.3912.3
201220.32164.3
5-Year Cumulative114 (16.4%/year)98.2 (14.7%/year)15.8 (1.7%/year)
2011-11.342.11-13.5
201025.9715.0610.9
200963.4226.4637.0
2008-48.25-37-11.2
2007-1.75.49-7.2
10-Year Cumulative98.7 (7.1%/year)95.7 (6.9%/year)3 (0.2%/year)
200610.3515.79-5.4
20050.924.91-4.0
200421.9710.8811.1
200328.0428.68-0.6
2002-5.18-22.116.9
15-Year Cumulative227.7 (8.2%/year)164.2 (6.7%/year)63.5 (1.5%/year)
200114.21-11.8926.1
200028.77-9.137.9
1999-5.7621.04-26.8
19989.8928.58-18.7
199736.4433.363.1
20-Year Cumulative581 (10.1%/year)339.2 (7.7%/year)241.8 (2.4%/year)
199623.5122.960.6
199518.5237.58-19.1
1994-4.221.32-5.5
19938.7310.08-1.4
199211.737.624.1
25-Year Cumulative1060 (10.3%/year)791.8 (9.1%/year)268.2 (1.2%/year)
199132.7230.472.3
1990-16.08-3.1-13.0
198925.1131.69-6.6
198839.9216.6123.3
198711.45.16.3
30-Year Cumulative2419.5 (11.4%/year)1719.7 (10.2%/year)699.8 (1.2%/year)

Top Ranked Articles

John Rogers Comments on Zimmer Biomet Holdings Guru stock highlight
Other holdings underperformed. Orthopedic specialist Zimmer Biomet Holdings, Inc. (NYSE:ZBH) fell –20.44% after cutting guidance and admitting internal supply issues. Earnings were in-line, but revenue was negatively impacted by inventory for some high-end products. The company subsequently cut full-year earnings guidance from $8.00 per share to $ 7.95 per share. We view the supply problem as a short-term issue and believe the long-term future is bright for this best-in-class brand. Read more...
John Rogers Comments on Thermo Fisher Scientific Inc. Guru stock highlight
Also, scientific research supplier Thermo Fisher Scientific Inc. (NYSE:TMO) dropped –11.20% despite an earnings beat. The company reported earnings per share of $2.03 in late October, well ahead of the $1.97 consensus estimate; it also closed its acquisition of electron microscope maker FEI Company. Health care stocks were generally weak in November and December as investors rotated away from defensive stocks toward more aggressive ones. In our view, the company remains on the right track. Read more...
John Rogers Comments on Contango Oil & Gas Co. Guru stock highlight
In addition, natural resources exploration and production company Contango Oil & Gas Co. (MCF) gained +83.93% as the price of oil recovered during the quarter. There was no other significant news beyond oil’s rebound—which was good news enough for Contango. Crude oil started 2016 at close to $37 per barrel, sank to a low of $26 in mid-February, then marched back above $40 before settling back a bit. Although the commodity essentially was flat, the rebound showed its year-and-a-half long slide has perhaps found a floor. We continue to think Contango has unrecognized value. Read more...
Ariel Funds Comments on Johnson & Johnson Guru stock highlight
Medical giant Johnson & Johnson (NYSE:JNJ) rallied +12.66%, due to a strong earnings report. In April the company beat analysts’ estimates and also raised guidance for the year. Earnings were driven by strong sales of drugs like Stelara and Xarelto. At this point pharmaceuticals are the company’s largest business division—ahead of powerhouses such as medical devices and consumer health products. We think the trajectory of the business continues to point upward. Read more...
Ariel Funds Comments on GlaxoSmithKline plc Guru stock highlight
In addition, GlaxoSmithKline plc (NYSE:GSK) rallied +7.74%1 in the second quarter, after reporting profit growth for the first time since 2013. Glaxo is seeing benefits from its purchase of Novartis’ vaccines unit. Demand for vaccines and new drugs helped offset declines in the sales of blockbuster asthma medication Advair. Read more...
» More John Rogers Articles

Commentaries and Stories

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Ariel Funds: Bank Stocks Are Overvalued Banks are coming back down to earth, vice president of John Rogers' firm says John Rogers - Ariel Funds: Bank Stocks Are Overvalued
Vice Chairman of John Rogers (Trades, Portfolio)' Ariel Investments, Charles Bobrinskoy, commented on the pullback in the market this week, saying bank stocks were very cheap in June, got to fair value the day after election, ran to overvalued and now are coming back to earth. He also believes regional bank stocks are too expensive. More...

  • Currently 5.00/5

Rating: 5.0/5 (2 votes)

John Rogers' Ariel Fund February Commentary A review of the month John Rogers - John Rogers' Ariel Fund February Commentary
Warren Buffett (Trades, Portfolio) often says, “Be greedy when others are fearful; be fearful when others are greedy.” While we do not think it is time for fear, it is certainly reasonable to be skeptical. We are not counseling pessimism but rather an intellectual caution leaning against groupthink and wide-eyed optimism—since there are some signs of market euphoria. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Brink's Insider Reduces Position in Company Director sells 900,000 shares Mario Gabelli, John Rogers, Jim Simons, Joel green - Brink's Insider Reduces Position In Company
Peter Feld, a director of The Brink’s Co. (NYSE:BCO), sold 900,000 shares in 40 transactions between March 3 and March 7, according to SEC filings. They were sold for an average price of $52.39 per share. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Insiders Invest in Edgewater Technology Directors purchase a combined 85,000 shares John Rogers, Mario Gabelli - Insiders Invest In Edgewater Technology
Edgewater Technology Inc. (NASDAQ:EDGW) directors purchased a combined 85,000 shares on March 3. More...

  • Currently 3.00/5

Rating: 3.0/5 (1 vote)

8 Stocks With Strong Yields but Falling Prices Companies that pay shareholders, but prices have performed poorly Jim Simons,John Rogers,Mario Gabelli,Chuck Royce - 8 Stocks With Strong Yields But Falling Prices
According to the GuruFocus All-in-One Screener, the following stocks have high dividend yields but performed poorly over the past 12 months. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

John Rogers' Ariel Fund January Commentary What happened in the month John Rogers - John Rogers' Ariel Fund January Commentary
In January, our monthly commentary typically focuses on the prior year’s asset flows, since they often a reveal a lot about investor sentiment. As we have noted before, asset flows have followed a different pattern in the wake of the great financial crisis. Specifically, bonds tended to receive inflows, domestic equity saw outflows, and passive management began dominating active management—mainly but not only in equities. More subtly, a long-standing preference for funds with strong short-term performance became even more pronounced. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

8 High-Yield Stocks With a Negative 1-Year Performance United-Guardian declined 23.1% Chuck Royce, John Rogers, Jim Simons, Mario Gabell - 8 High-Yield Stocks With A Negative 1-Year Performance
According to the GuruFocus All-in-One Screener, the following stocks have high dividend yields but performed poorly over the past 12 months. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

John Rogers Comments on JLL Guru stock highlight
Also, real estate company JLL (NYSE:JLL) declined –10.89% on disappointing earnings. In early November the company reported quarterly earnings of $1.42, significantly below consensus of $2.00. Revenues were strong, but the impact of an acquisition, higher technology spending, a decline in incentive fees, and a significant write-down of receivables all hurt the bottom line. We think the quarter featured a rare confluence of one-time factors. To our minds, the long-term value of one of the top two global real estate players remains stable. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

John Rogers Comments on Charles River Laboratories Intl Guru stock highlight
Other holdings underperformed. Scientific research firm Charles River Laboratories Intl, Inc. (NYSE:CRL) slid –8.58% due to contracting customer spending and a general downturn in health care stocks. Like other similar firms, Charles River expanded over the last 15 years to be able to handle peak medical research, but as drug companies scaled back, there was clearly overcapacity. The company’s drug discovery business is still a bit slack. That said, many health care stocks slid this quarter during a huge rotation to financials. We think the current issues are largely cyclical but the secular push toward solving medical problems through pharmaceuticals remains intact—a long-term tailwind for Charles River. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

John Rogers Comments on Keysight Technologies Guru stock highlight
In the last quarter of the year, we added one new position in Ariel Appreciation Fund We purchased Keysight Technologies, Inc. (NYSE:KEYS), a leading test and measurement business for electronics. The company’s long history dates back to its formation as the measurement business of Hewlett-Packard (NYSE:HPE), which has resulted in deeply rooted relationships, leading market share, and a seat at the table during the development of new technologies. Recently spun-off from Agilent Technologies, Inc. (NYSE:A), investors are discarding the shares due to a perceived lack of near-term growth prospects. We see this as an attractive long-term opportunity to own a niche market leader with excellent free cash flow generation. We think it is well-positioned to benefit from several longer-term tailwinds, including 5G wireless testing and growing demand for modular solutions, software-based testing and More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

John Rogers Comments on Thermo Fisher Scientific Inc. Guru stock highlight
Also, scientific research supplier Thermo Fisher Scientific Inc. (NYSE:TMO) dropped –11.20% despite an earnings beat. The company reported earnings per share of $2.03 in late October, well ahead of the $1.97 consensus estimate; it also closed its acquisition of electron microscope maker FEI Company. Health care stocks were generally weak in November and December as investors rotated away from defensive stocks toward more aggressive ones. In our view, the company remains on the right track. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

John Rogers Comments on Zimmer Biomet Holdings Guru stock highlight
Other holdings underperformed. Orthopedic specialist Zimmer Biomet Holdings, Inc. (NYSE:ZBH) fell –20.44% after cutting guidance and admitting internal supply issues. Earnings were in-line, but revenue was negatively impacted by inventory for some high-end products. The company subsequently cut full-year earnings guidance from $8.00 per share to $ 7.95 per share. We view the supply problem as a short-term issue and believe the long-term future is bright for this best-in-class brand. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

John Rogers Comments on Northern Trust Corp Guru stock highlight
In addition, wealth management firm Northern Trust Corp. (NASDAQ:NTRS) surged +31.58% on broad news that boosted many financial companies. Donald Trump’s unexpected win is good news for banks, asset managers, and investment banks. And, as anticipated, in mid-December the Federal Reserve raised its federal funds target rate 25 basis points to the 0.50% to 0.75% range, which helps boost bank profits on deposits. The Northern Trust is performing well, but its recent rise was due to external events. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

John Rogers Comments on Bristow Group Inc. Guru stock highlight
Some holdings in the portfolio advanced considerably. Helicopter transportation company Bristow Group Inc. (NYSE:BRS) ascended +46.83% after recently secured financing put Wall Street at ease. The Street had worried the company would become financially distressed like a top competitor given the oil industry’s woes. Instead, Bristow arranged $300 million in debt, secured by a portion of its own helicopter fleet. In addition, oil rose during the year and the quarter, giving the stock a mild boost as well. We think its shares are undervalued given the company’s significant assets and depressed earnings. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

John Rogers' Ariel Fund 4th Quarter Commentary Discussion of quarter and holdings John Rogers - John Rogers' Ariel Fund 4th Quarter Commentary
Entering the fourth quarter of 2016, it appeared domestic stocks would have a solid year and international equities a lackluster, yet positive one. After a divergent quarter, we had a great year in the U.S. and a flat year abroad. For 2016, the large-cap S&P 500 Index gained +11.96%, the small-cap Russell 2000 Index leapt +21.31%, while the developed-market MSCI EAFE Index eked out a +1.00% gain. As many know, the big surge after the surprising U.S. Presidential Election became known as the “Trump Bump.” The disparity between large-caps’ single digit fourth quarter gains and small-caps’ big run stems from the President-Elect’s plan to slash corporate taxes. Perhaps more importantly, however, the gains suggest optimism the economic expansion will continue. Globally, pessimism has held sway for some time. Since a July 3, 2014 peak, the MSCI EAFE Index is down -9.23% cumulatively through December 31, 2016. This index is clearly in a bear market: down for two and a half years and at one point off -22.15% cumulatively. This quarter, Ariel Fund gained +7.75%, behind the Russell 2500 Value Index’s +9.34% gain but ahead of the +6.12% rise of the Russell 2500 Index. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

John Rogers' Ariel Appreciation Fund 4th Quarter Commentary Review of quarter and holdings John Rogers - John Rogers' Ariel Appreciation Fund 4th Quarter Commentary
Quarter Ended December 31, 2016 More...

  • Currently 4.00/5

Rating: 4.0/5 (2 votes)

John Rogers Muses on Risk in Ariel Funds December Commentary Outlook on markets and strategy John Rogers - John Rogers Muses On Risk In Ariel Funds December Commentary
Happy New Year to you and Happy Birthday to our global portfolios! Two years ago we celebrated their three-year records and first set of Morningstar Ratings, so it makes sense to do so again as they turn five. We think we have reason to be proud of Ariel International Fund and Ariel Global Fund’s performance and hope you agree. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Gilead Sciences Must Answer to Investors After a Disappointing 2016 Investors are concerned about the company's lack of a plan for the future David Dreman,John Rogers - Gilead Sciences Must Answer To Investors After A Disappointing 2016
Gilead Sciences Inc. (NASDAQ:GILD) delivered a poor performance last year. The stock lost over 24% in 2016, caused by a drop in sales of products that treat hepatitis C. According to Ben Levinsohn in a Barron's article, the decline was also attributed to the company’s lack of a plan for the future. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Gurus Expand Positions in Entertainment and Travel Companies Analysis of institutional and insider ownership Steven Cohen, John Rogers, PRIMECAP - Gurus Expand Positions In Entertainment And Travel Companies
Among the industries, the entertainment and travel industries have high institutional and insider ownership. Such companies include Cinemark Holdings Inc. (NYSE:CNK), Century Casinos Inc. (NASDAQ:CNTY) and Royal Caribbean Cruises Ltd. (NYSE:RCL). As gurus expand their positions in these companies, such companies have good value potential in early 2017. More...

STEVEN COHEN, JOHN ROGERS, PRIMECAP MANAGEMENT


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

John Rogers Boosts Berkshire, Rockwell Collins, Tiffany The founder of Ariel Investment's largest buys of the 3rd quarterom Ru John Rogers,Bill Gates,Ken Fisher,Ruane Cunniff,Da - John Rogers Boosts Berkshire, Rockwell Collins, Tiffany
John Rogers (Trades, Portfolio) founded Ariel Investment LLC in 1983, and the firm now has a total value of $8.267 billion. During the third quarter the guru’s largest buys were the following: More...

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Latest Guru Stock Picks


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK